πŸ”₯πŸ” BizChicken πŸ”πŸ”₯

Companies Similar to OncoCyte Corporation

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Co-Diagnostics, Inc.

Co-Diagnostics, Inc. logo
Market Cap: Lowest
Employees: Low

PCR diagnostic tests

Co-Diagnostics, Inc. develops, manufactures, and sells reagents for diagnostic tests that detect nucleic acid molecules, offering PCR tests for various diseases including COVID-19 and providing molecular diagnostic tools for healthcare and agricultural applications.

Tags: Agriculture, Genetic Testing, Healthcare, Infectious Diseases, Molecular Diagnostics, PCR Tests, Point-of-Care

Symbol: CODX

Recent Price: $0.70

Industry: Medical - Devices

CEO: Mr. Dwight H. Egan

Sector: Healthcare

Employees: 155

Address: 2401 South Foothill Drive, Salt Lake City, UT 84109

Phone: 801 438 1036

Last updated: 2024-12-31

CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc. logo
Market Cap: Low
Employees: Low

Probody technology platform

Cytom X Therapeutics, Inc. is an oncology-focused biopharmaceutical company that develops antibody therapeutics based on its Probody technology platform for treating cancer. Its product candidates include CX-2009, CX-2029, BMS-986249, BMS-986288, CX-2043, and CX-904, targeting various cancers and currently in clinical trials.

Tags: antibody therapeutics, biopharmaceuticals, cancer treatment, clinical trials, oncology

Symbol: CTMX

Recent Price: $1.02

Industry: Biotechnology

CEO: Dr. Sean A. McCarthy DPHIL

Sector: Healthcare

Employees: 120

Address: 151 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 650 515 3185

Last updated: 2024-12-31

Castle Biosciences, Inc.

Castle Biosciences, Inc. logo
Market Cap: Medium
Employees: Medium

Decision Dx-Melanoma

Castle Biosciences, Inc. is a commercial-stage diagnostics company providing diagnostic and prognostic testing services for dermatological cancers, including products like Decision Dx-Melanoma for invasive cutaneous melanoma and other proprietary GEP tests.

Tags: dermatological cancers, diagnostics, metastasis risk, multi-gene expression profile, squamous cell carcinoma, uveal melanoma

Symbol: CSTL

Recent Price: $26.66

Industry: Medical - Diagnostics & Research

CEO: Mr. Derek J. Maetzold

Sector: Healthcare

Employees: 710

Address: 505 South Friendswood Drive, Friendswood, TX 77546

Phone: 866 788 9007

Leadership

  • Derek Maetzold, Founder, President, CEO and Director
  • Frank Stokes, Chief Financial Officer
  • Kristen Oelschlager, CHIEF OPERATING OFFICER
  • Toby Juvenal, CHIEF COMMERCIAL OFFICER
  • Sherri Borman, Ph.D., Executive Laboratory Director
  • John Abbott, VICE PRESIDENT, FINANCE
  • Rebecca Critchley-Thorne, Ph.D., vice president, research & development
  • Jay Braxton, Pharm.D., Vice President, Marketing and brand manager, uveal melanoma (um)
  • Hillary Caruso, Ph.D., Vice President, Strategic Operations
  • John Cheneval, Executive Director, Business Development
  • Kevin Doman, Vice President, Sales
  • Vicki Fish, Vice President, Skin Cancer Marketing
  • Matthew Goldberg, M.D., Senior vice president, medical
  • Keli Greenberg, Vice President, Human Resources
  • Alice Izzo, Vice President, regulatory and government affairs
  • Clare Johnson, R.N., Vice President, Clinical Research
  • Michael Maltby, Executive Director, Managed Care
  • Noreen Manning, Vice President, Reimbursement
  • Chris Otte, Vice President, Information Technology
  • Trisha Poteet, Vice President, Clinical Services
  • Camilla Zuckero, Vice President, Investor Relations & Corporate Affairs
  • Daniel Bradbury, Board Chairman
  • Kimberlee Caple, Director
  • G. Bradley Cole, Director
  • Rodney Cotton, Director
  • Ellen Goldberg, Director
  • Miles Harrison, Director
  • Tiffany Olson, Director

Last updated: 2024-12-31

PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. logo
Market Cap: Lowest
Employees: Lowest

Cell-in-a-Box

Pharma Cyte Biotech, Inc. is a biotechnology company focused on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites. Their therapies are based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology, used for treating various cancers and diabetes.

Tags: Cell-in-a-Box, biotechnology, cancer, cannabis plant, cellular therapies, diabetes, insulin-dependent diabetes, live cell encapsulation, pancreatic cancer

Symbol: PMCB

Recent Price: $1.55

Industry: Biotechnology

CEO: Mr. Joshua N. Silverman

Sector: Healthcare

Employees: 2

Address: 3960 Howard Hughes Parkway, Las Vegas, NV 89169

Phone: 917 595 2850

Leadership

  • Joshua N. Silverman, Independent Director
  • Dr. Michael M. Abecassis, Independent Director
  • Robert Weinstein, Director
  • Wayne R. Walker, Director
  • Jonathan L. Schechter, Independent Director
  • Dr. Abecassis, Director
  • Kenneth L. Waggoner, Independent Director
  • Daniel C. Farb, Independent Director
  • Daniel C. Allen, Independent Director
  • Jack E. Stover, Independent Director

Last updated: 2024-12-31

QuidelOrtho Corporation

QuidelOrtho Corporation logo
Market Cap: High
Employees: Highest

Diagnostic Testing Technologies

Quidel Ortho Corporation develops and manufactures diagnostic testing technologies for healthcare, operating through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics units.

Tags: Diagnostic Testing, Healthcare, Labs, Molecular Diagnostics, Point-of-Care, Transfusion Medicine

Symbol: QDEL

Recent Price: $44.00

Industry: Medical - Instruments & Supplies

CEO: Mr. Brian J. Blaser

Sector: Healthcare

Employees: 7100

Address: 9975 Summers Ridge Road, San Diego, CA 92121

Phone: 858 552 1100

Last updated: 2024-12-31

Pyxis Oncology, Inc.

Pyxis Oncology, Inc. logo
Market Cap: Low
Employees: Lowest

PYX-106, PYX-102, PYX-201, PYX-202, PYX-203

Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, focuses on developing therapies to treat various cancers through immune-oncology and antibody drug conjugate product candidates.

Tags: antibody drug conjugate, biopharmaceutical, cancer therapy, immune-oncology, solid tumors

Symbol: PYXS

Recent Price: $1.56

Industry: Biotechnology

CEO: Dr. Lara S. Sullivan M.D., MBA

Sector: Healthcare

Employees: 55

Address: 35 Cambridgepark Drive, Cambridge, MA 02140

Phone: 617 221 9059

Last updated: 2024-12-31

Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

REN001

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.

Tags: Clinical Trials, Genetic Disorders, Mitochondrial Diseases, Pharmaceuticals, Therapeutics

Symbol: RPHM

Recent Price: $18.20

Industry: Biotechnology

CEO: Mr. Gregory J. Flesher

Sector: Healthcare

Employees: 8

Address: 18575 Jamboree Road, Irvine, CA 92612

Phone: 619 733 3852

Last updated: 2024-12-31

T2 Biosystems, Inc.

T2 Biosystems, Inc. logo
Market Cap: Lowest
Employees: Low

T2Dx Instrument

T2 Biosystems, Inc. develops in vitro diagnostic products for detecting pathogens, biomarkers, and abnormalities in various patient sample types.

Tags: SARS-CoV-2, T2Dx Instrument, bacterial pathogens, biomarkers, biothreat detection, candidemia, carbapenem resistance, in vitro diagnostics, pathogen detection, sepsis

Symbol: TTOO

Recent Price: $0.42

Industry: Medical - Diagnostics & Research

CEO: Mr. John J. Sperzel III, B.Sc.

Sector: Healthcare

Employees: 113

Address: 101 Hartwell Avenue, Lexington, MA 02421

Phone: 781 761 4646

Leadership

  • John Sperzel, Chairman and Chief Executive Officer
  • Michael Gibbs, Esq., SVP and General Counsel
  • Brett Giffin, Chief Commercial Officer
  • Kelley Morgan, Chief People Officer
  • Roger Smith, SVP, Science, Research and Development
  • John Sprague, Chief Financial Officer
  • Laura Adams, Special Advisor at the National Academy of Medicine (NAM)
  • John W. Cumming, CEO and Managing Director, Cumming & Associates LLC
  • David Elsbree, Former Senior Partner, Deloitte & Touche
  • Dr. Ninfa M. Saunders, FACHE, President and CEO, Navicent Health
  • Robin Toft, Founder and CEO, Toft Group

Last updated: 2024-12-31

Agenus Inc.

Agenus Inc. logo
Market Cap: Low
Employees: Medium

Retrocyte Display

Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.

Tags: antibody expression, cancer treatment, clinical trials, immuno-oncology, vaccine development

Symbol: AGEN

Recent Price: $2.69

Industry: Biotechnology

CEO: Dr. Garo H. Armen Ph.D.

Sector: Healthcare

Employees: 389

Address: 3 Forbes Road, Lexington, MA 02421-7305

Phone: 781 674 4400

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

Celcuity Inc.

Celcuity Inc. logo
Market Cap: Medium
Employees: Lowest

CELsignia diagnostic platform

Celcuity Inc., a biotechnology company, develops targeted therapies for cancer patients in the US, including the CELsignia diagnostic platform and Gedatolisib drug candidate.

Tags: Gedatolisib, HER2-negative, biotechnology, breast cancer, cancer therapy, diagnostic platform

Symbol: CELC

Recent Price: $13.13

Industry: Biotechnology

CEO: Mr. Brian F. Sullivan

Sector: Healthcare

Employees: 55

Address: 16305–36th Avenue North, Minneapolis, MN 55446

Phone: 763 392 0767

Leadership

  • Brian Sullivan, CEO and Co-founder
  • Lance Laing, PhD, Chief Science Officer and Co-founder
  • Vicky Hahne, CFO
  • Igor Gorbatchevsky, MD, Chief Medical Officer
  • Eldon Mayer, Chief Commercial Officer
  • Brent Eilefson, General Counsel
  • Bernhard Lampert, PhD, VP of Pharmaceutical Development
  • Nadene Zack, VP Clinical Operations
  • Sunni Miller, VP of Regulatory Affairs
  • David Bridge, VP of Quality Assurance and Process Development
  • William Strickland, PharmD, VP of Medical Affairs
  • Fred Kerwood, VP of Program Management
  • Charlotte Moser, MD, PhD, SVP of Clinical Development
  • John R. MacDonald, PhD, SVP of R&D
  • Lance Laing, PhD, Chief Science Officer and Co-Founder
  • Richard Buller, MD, PhD, Director
  • David F. Dalvey, Director
  • Leo Furcht, MD, Director
  • Polly Murphy, DVM, PhD, Director
  • Richard J. Nigon, Director

Last updated: 2024-12-31

Celularity Inc.

Celularity Inc. logo
Market Cap: Lowest
Employees: Low

CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.

Tags: biotechnology, cancer, cell therapies, immune diseases, infectious diseases, placental-derived

Symbol: CELU

Recent Price: $2.05

Industry: Biotechnology

CEO: Dr. Robert Joseph Hariri M.D., Ph.D.

Sector: Healthcare

Employees: 120

Address: 170 Park Avenue, Florham Park, NJ 07932

Phone: 908 768 2170

Leadership

  • Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
  • David Beers, CFA, Chief Financial Officer
  • Stephen Brigido, DPM, President, Degenerative Diseases
  • John Haines, Global Manager and Chief Administrative Officer
  • K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
  • John Colerangle, DVM, Ph.D., Regulatory Affairs
  • Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
  • Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
  • Carmine Palummo, Corporate Operations
  • Tim Wilk, Technical Operations
  • Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
  • Peter Diamandis, M.D., Director
  • Dean Kehler, Director
  • Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
  • Diane Parks, Director

Last updated: 2024-12-31

Coherus BioSciences, Inc.

Coherus BioSciences, Inc. logo
Market Cap: Low
Employees: Low

UDENYCA

Coherus Bio Sciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. It markets UDENYCA and develops various biosimilar and immuno-oncology products.

Tags: Toripalimab, UDENYCA, biopharmaceutical, biosimilars, immuno-oncology

Symbol: CHRS

Recent Price: $1.50

Industry: Biotechnology

CEO: Mr. Dennis M. Lanfear

Sector: Healthcare

Employees: 306

Address: 333 Twin Dolphin Drive, Redwood City, CA 94065

Phone: 650 649 3530

Last updated: 2024-12-31

4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

4D-125, 4D-110, 4D-310, 4D-150, 4D-710

4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company developing product candidates using adeno-associated virus vectors, focusing on ophthalmology, cardiology, and pulmonology.

Tags: biotechnology, cardiology, gene therapy, ophthalmology, pulmonology

Symbol: FDMT

Recent Price: $5.30

Industry: Biotechnology

CEO: Dr. David H. Kirn M.D.

Sector: Healthcare

Employees: 201

Address: 5858 Horton Street, EmeryVille, CA 94608

Phone: 510 505 2680

Last updated: 2024-12-31

Myriad Genetics, Inc.

Myriad Genetics, Inc. logo
Market Cap: High
Employees: High

My Risk Hereditary Cancer Test

Myriad Genetics, Inc. is a genetic testing and precision medicine company that develops and commercializes genetic tests for oncology, women's health, and mental health applications.

Tags: DNA sequencing, genetic testing, mental health, oncology, precision medicine, women's health

Symbol: MYGN

Recent Price: $13.63

Industry: Medical - Diagnostics & Research

CEO: Mr. Paul J. Diaz

Sector: Healthcare

Employees: 2700

Address: 320 Wakara Way, Salt Lake City, UT 84108

Phone: 801 584 3600

Last updated: 2024-12-31

OncoCyte Corporation

OncoCyte Corporation logo
Market Cap: Lowest
Employees: Lowest

Determa Rx

Onco Cyte Corporation, based in Irvine, California, develops and commercializes molecular diagnostics tests for cancer detection, including Determa Rx and Determa IO.

Tags: biomarker discovery, cancer detection, clinical trial support, gene expression assay, molecular diagnostics

Symbol: OCX

Recent Price: $2.45

Industry: Biotechnology

CEO: Mr. Joshua Riggs

Sector: Healthcare

Employees: 43

Address: 15 Cushing, Irvine, CA 92618

Phone: 949 409 7600

Leadership

  • Josh Riggs, President & Chief Executive Officer
  • Prof. Dr. Ekkehard SchΓΌtz, MD, PhD, FAACC, Chief Science Officer
  • Yuh-Min (Johnson) Chiang, PhD, Chief Technology Officer
  • Andrea James, Chief Financial Officer
  • Sandra O’Donald, Senior Vice President, Business Operations
  • Ryan Andrews, Vice President, Commercial
  • Peter Hong, Vice President, General Counsel
  • James Liu, Senior Director, Controller & Principal Accounting Officer

Last updated: 2024-12-31

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc. logo
Market Cap: High
Employees: Medium

Crysvita, Mepsevii, Dojolvi, Evkeeza, DTX401, DTX301

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the development and commercialization of products for rare and ultra-rare genetic diseases worldwide.

Tags: Crysvita, Dojolvi, Evkeeza, Mepsevii, biopharmaceutical, gene therapy, genetic diseases, rare diseases

Symbol: RARE

Recent Price: $42.27

Industry: Biotechnology

CEO: Dr. Emil D. Kakkis M.D., Ph.D.

Sector: Healthcare

Employees: 1276

Address: 60 Leveroni Court, Novato, CA 94949

Phone: 415 483 8800

Last updated: 2024-12-31

Veracyte, Inc.

Veracyte, Inc. logo
Market Cap: High
Employees: Medium

Afirma Genomic Sequencing Classifier, Xpression Atlas, Decipher Prostate, Prosigna Breast Cancer Assay, Percepta Genomic Sequencing Classifier, Envisia Genomic Classifier, Immunoscore Colon Cancer test

Veracyte, Inc. operates as a diagnostics company worldwide, providing genomic testing solutions for various cancers and diseases, aiming to improve outcomes by avoiding unnecessary surgeries and enhancing treatment decisions.

Tags: Biotechnology, Cancer Diagnosis, Diagnostics, Genomic Testing, Healthcare, Medical Devices

Symbol: VCYT

Recent Price: $40.00

Industry: Biotechnology

CEO: Mr. Marc A. Stapley

Sector: Healthcare

Employees: 815

Address: 6000 Shoreline Court, South San Francisco, CA 94080

Phone: 650 243 6300

Last updated: 2024-12-31

Quest Diagnostics Incorporated

Quest Diagnostics Incorporated logo
Market Cap: Highest
Employees: Highest

Diagnostic Information Services

Quest Diagnostics Incorporated offers a range of diagnostic testing and information services, including routine and advanced clinical testing, anatomic pathology, and risk assessment services for the life insurance industry, supported by a global network of laboratories and service professionals.

Tags: clinical testing, diagnostic testing, health IT, healthcare services, life insurance risk assessment, pathology

Symbol: DGX

Recent Price: $150.97

Industry: Medical - Diagnostics & Research

CEO: Mr. James E. Davis

Sector: Healthcare

Employees: 50000

Address: 500 Plaza Drive, Secaucus, NJ 07094

Phone: 973 520 2700

Last updated: 2024-12-31

The Oncology Institute, Inc.

The Oncology Institute, Inc. logo
Market Cap: Lowest
Employees: Medium

Medical Oncology Services

An oncology company providing medical oncology services in the United States, including clinical trials, radiation, outpatient stem cell transplants, and patient support, serving adult and senior cancer patients with 67 clinic locations.

Tags: Cancer Care, Clinical Trials, Medical Services, Oncology, Patient Support, Stem Cell Transplants

Symbol: TOI

Recent Price: $0.32

Industry: Medical - Care Facilities

CEO: Dr. Daniel Virnich FACHE, M.B.A., M.D.

Sector: Healthcare

Employees: 800

Address: 18000 Studebaker Road, Cerritos, CA 90703

Phone: 213 760 1328

Last updated: 2024-12-31